论文部分内容阅读
目的分析氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效。方法 70例高血压合并冠心病患者,依据治疗方法不同分为参照组和研究组,各35例。参照组患者接受氨氯地平治疗,研究组患者接受氨氯地平阿托伐他汀钙片治疗,比较两组治疗效果。结果研究组收缩压、舒张压、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)以及高密度脂蛋白胆固醇(HDL-C)水平均明显优于参照组,差异具有统计学意义(t=6.7454、42.3515、3.0384、4.6190、2.9750、2.2712,P<0.05)。两组不良反应发生率比较差异无统计学意义(χ~2=0.2154,P>0.05)。结论高血压合并冠心病予以氨氯地平阿托伐他汀钙片治疗疗效确切,患者的血压和血脂水平可以有效改善,临床应用价值高。
Objective To analyze the clinical efficacy of amlodipine atorvastatin calcium in the treatment of patients with hypertension and coronary heart disease. Methods Seventy patients with hypertension and coronary heart disease were divided into the reference group and the study group according to the different treatment methods, 35 cases in each. Patients in the reference group received amlodipine, and patients in the study group received amlodipine atorvastatin calcium tablets. The treatment effect was compared between the two groups. Results The systolic blood pressure, diastolic blood pressure, triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) , The difference was statistically significant (t = 6.7454,42.3515,3.0384,4.6190,2.9750,2.2712, P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (χ ~ 2 = 0.2154, P> 0.05). Conclusions Hypertension with coronary heart disease is treated with amlodipine atorvastatin calcium tablets. The patients’ blood pressure and blood lipid level can be effectively improved, and their clinical value is high.